These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27841001)

  • 21. Resveratrol attenuates bone cancer pain through the inhibition of spinal glial activation and CX3CR1 upregulation.
    Cheng W; Zhao Y; Liu H; Fan Q; Lu FF; Li J; Yin Q; Yan CD
    Fundam Clin Pharmacol; 2014 Dec; 28(6):661-70. PubMed ID: 24872145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrathecal injection of metabotropic glutamate receptor subtype 3 and 5 agonist/antagonist attenuates bone cancer pain by inhibition of spinal astrocyte activation in a mouse model.
    Ren BX; Gu XP; Zheng YG; Liu CL; Wang D; Sun YE; Ma ZL
    Anesthesiology; 2012 Jan; 116(1):122-32. PubMed ID: 22123524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spinal RhoA/Rho kinase signalling pathway may participate in the development of bone cancer pain.
    Hang LH; Shao DH; Chen Z; Sun WJ
    Basic Clin Pharmacol Toxicol; 2013 Aug; 113(2):87-91. PubMed ID: 23521814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrathecal midazolam regulates spinal AMPA receptor expression and function after nerve injury in rats.
    Lim J; Lim G; Sung B; Wang S; Mao J
    Brain Res; 2006 Dec; 1123(1):80-8. PubMed ID: 17049496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabinoid receptor 2‑selective agonist JWH015 attenuates bone cancer pain through the amelioration of impaired autophagy flux induced by inflammatory mediators in the spinal cord.
    Mao Y; Huang Y; Zhang Y; Wang C; Wu H; Tian X; Liu Y; Hou B; Liang Y; Rong H; Gu X; Ma Z
    Mol Med Rep; 2019 Dec; 20(6):5100-5110. PubMed ID: 31661120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic interactions between midazolam and alfentanil in isolated neonatal rat spinal cord.
    Feng J; Kendig JJ
    Br J Anaesth; 1996 Sep; 77(3):375-80. PubMed ID: 8949814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contributions of spinal D-amino acid oxidase to bone cancer pain.
    Huang JL; Chen XL; Guo C; Wang YX
    Amino Acids; 2012 Nov; 43(5):1905-18. PubMed ID: 22996731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sigma-1 Receptor Antagonist BD1047 Reduces Mechanical Allodynia in a Rat Model of Bone Cancer Pain through the Inhibition of Spinal NR1 Phosphorylation and Microglia Activation.
    Zhu S; Wang C; Han Y; Song C; Hu X; Liu Y
    Mediators Inflamm; 2015; 2015():265056. PubMed ID: 26696751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of bone cancer pain by HSV-1-mediated silencing of CNTF in an afferent area of the spinal cord associated with AKT-ERK signal inhibition.
    Yang X; Liu J; Liu ZJ; Xia QJ; He M; Liu R; Liu W; Wang W; Liu J; Zhou XF; Zhang YH; Wang TH
    Curr Gene Ther; 2014; 14(5):377-88. PubMed ID: 25687503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The spinal nitric oxide involved in the inhibitory effect of midazolam on morphine-induced analgesia tolerance.
    Cao JL; Ding HL; He JH; Zhang LC; Duan SM; Zeng YM
    Pharmacol Biochem Behav; 2005 Mar; 80(3):493-503. PubMed ID: 15740792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of HDAC2 in Spinal Cord Alleviates Mechanical Hyperalgesia and Restores KCC2 Expression in a Rat Model of Bone Cancer Pain.
    Hou X; Weng Y; Wang T; Ouyang B; Li Y; Song Z; Pan Y; Zhang Z; Zou W; Huang C; Guo Q
    Neuroscience; 2018 May; 377():138-149. PubMed ID: 29482000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of CX3CR1 in bone cancer pain through the activation of microglia p38 MAPK pathway in the spinal cord.
    Hu JH; Yang JP; Liu L; Li CF; Wang LN; Ji FH; Cheng H
    Brain Res; 2012 Jul; 1465():1-9. PubMed ID: 22613229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SIRT1 Activation Attenuates Bone Cancer Pain by Inhibiting mGluR1/5.
    Yang C; Kang F; Wang S; Han M; Zhang Z; Li J
    Cell Mol Neurobiol; 2019 Nov; 39(8):1165-1175. PubMed ID: 31270711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. STAT3 inhibitor WP1066 as a novel therapeutic agent for bCCI neuropathic pain rats.
    Xue ZJ; Shen L; Wang ZY; Hui SY; Huang YG; Ma C
    Brain Res; 2014 Oct; 1583():79-88. PubMed ID: 25084036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prolonged analgesic effect of epidural ropivacaine in a rat model of neuropathic pain.
    Sato C; Sakai A; Ikeda Y; Suzuki H; Sakamoto A
    Anesth Analg; 2008 Jan; 106(1):313-20, table of contents. PubMed ID: 18165597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrathecal injection of lentivirus-mediated glial cell line-derived neurotrophic factor RNA interference relieves bone cancer-induced pain in rats.
    Meng FF; Xu Y; Dan QQ; Wei L; Deng YJ; Liu J; He M; Liu W; Xia QJ; Zhou FH; Wang TH; Wang XY
    Cancer Sci; 2015 Apr; 106(4):430-7. PubMed ID: 25611164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antinociceptive effect of prostatic acid phosphatase in a rat model of cancer-induced bone pain.
    Chen L; Zhu L; Wang K; Wang W; Mei XP; Liu T; Zhang FX; Wang W; Chen T; Li YQ
    Pain Physician; 2013; 16(6):533-46. PubMed ID: 24284839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The short interference RNA (siRNA) targeting NMUR2 relieves nociception in a bone cancer pain model of rat through PKC-ERK and PI3K-AKT pathways.
    Peng S; Lu Y; Li P; Liu P; Shi X; Liu C; Zhang Y; Liu S; Wang J
    Biochem Biophys Res Commun; 2019 May; 512(3):616-622. PubMed ID: 30914203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resveratrol suppresses bone cancer pain in rats by attenuating inflammatory responses through the AMPK/Drp1 signaling.
    Hao M; Tang Q; Wang B; Li Y; Ding J; Li M; Xie M; Zhu H
    Acta Biochim Biophys Sin (Shanghai); 2020 Mar; 52(3):231-240. PubMed ID: 32072182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Curcumin analogue NL04 inhibits spinal cord central sensitization in rats with bone cancer pain by inhibiting NLRP3 inflammasome activation and reducing IL-1β production.
    Chen L; Hua B; He Q; Han Z; Wang Y; Chen Y; Ni H; Zhu Z; Xu L; Yao M; Ni C
    Eur J Pharmacol; 2024 May; 970():176480. PubMed ID: 38490468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.